AKT1 and chronic obstructive pulmonary disease: In patients with COPD, reduced IGF-1 levels in skeletal muscles led to decreased muscle protein synthesis by inhibiting the muscle hypertrophy pathway IGF-1-phosphoinositide 3-kinase-protein kinase B (Akt) [15,69].